{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T19:34:50Z","timestamp":1791056090574,"version":"4.1.0"},"reference-count":37,"publisher":"American Society for Microbiology","issue":"11","license":[{"start":{"date-parts":[[2000,11,1]],"date-time":"2000-11-01T00:00:00Z","timestamp":973036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[2000,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Tumor necrosis factor (TNF)-deficient mice were challenged with<jats:italic>Leishmania donovani<\/jats:italic>to characterize TNF in the response of visceral intracellular infection to antileishmanial chemotherapy. In wild-type controls (i) liver infection peaked at week 2 and resolved, (ii) discrete liver granulomas developed at weeks 2 to 4 and involuted, and (iii) leishmanicidal responses to antimony (Sb), amphotericin B (AmB), and miltefosine were intact. In TNF knockout (KO) mice (i) initial liver infection was unrestrained, plateaued, and then declined somewhat by week 6, (ii) an absent early granulomatous reaction abruptly accelerated with striking tissue inflammation, widespread hepatic necrosis, and 100% mortality by week 10, and (iii) while the initial response to AmB and miltefosine was intact, killing induced by Sb therapy was reduced by &gt;50%. Although initial AmB treatment during weeks 2 to 3 killed 98% of liver parasites, 75% of AmB-treated KO mice subsequently relapsed and died by week 12; however, additional maintenance AmB preserved long-term survival. These results for a model of visceral infection indicate that endogenous TNF is required early on to control intracellular<jats:italic>L. donovani<\/jats:italic>, support granuloma development, and mediate optimal initial effects of Sb and prevent relapse after ordinarily curative AmB treatment. A compensatory, TNF-independent antileishmanial mechanism developed in TNF KO mice; however, its effect was uncontrolled fatal inflammation. Chemotherapeutic elimination of the parasite stimulus reversed the hyperinflammatory response and preserved survival.<\/jats:p>","DOI":"10.1128\/iai.68.11.6289-6293.2000","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:01:09Z","timestamp":1027764069000},"page":"6289-6293","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":90,"title":["Visceral Leishmaniasis in Mice Devoid of Tumor Necrosis Factor and Response to Treatment"],"prefix":"10.1128","volume":"68","author":[{"given":"Henry W.","family":"Murray","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Department of Medicine, Weill Medical College of Cornell University,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achim","family":"Jungbluth","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Ludwig Institute for Cancer Research, New York Branch at Memorial Sloan-Kettering Cancer Center,2 New York, New York 10021"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Ritter","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Ludwig Institute for Cancer Research, New York Branch at Memorial Sloan-Kettering Cancer Center,2 New York, New York 10021"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Montelibano","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Medicine, Weill Medical College of Cornell University,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Marino","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Ludwig Institute for Cancer Research, New York Branch at Memorial Sloan-Kettering Cancer Center,2 New York, New York 10021"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.4049\/jimmunol.162.6.3504","article-title":"Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin","volume":"162","author":"Bean A. G. D.","year":"1999","unstructured":"Bean A. G. D. Roach D. R. Briscoe H. France M. P. Korner H. Sedgwick J. D. Britton W. J. Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin.J. Immunol.162199935043511","journal-title":"J. Immunol."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199310001-00003"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4049\/jimmunol.157.1.12","article-title":"IL-10 production is enhanced in human T cells by IL-12 and IL-6 and in monocytes by tumor necrosis factor-\u03b1","volume":"157","author":"Daftarian P. M.","year":"1996","unstructured":"Daftarian P. M. Kumar A. Kryworuchko M. Diaz-Mitoma F. IL-10 production is enhanced in human T cells by IL-12 and IL-6 and in monocytes by tumor necrosis factor-\u03b1.J. Immunol.15719961220","journal-title":"J. Immunol."},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.4049\/jimmunol.160.7.3427","article-title":"Crucial role of TNF receptor type 1 (p55), but not of TNF receptor type 2 (p75) in murine toxoplasmosis","volume":"160","author":"Deckert-Schluter M.","year":"1998","unstructured":"Deckert-Schluter M. Bluethmann H. Rang A. Hof H. Schluter D. Crucial role of TNF receptor type 1 (p55), but not of TNF receptor type 2 (p75) in murine toxoplasmosis.J. Immunol.160199834273436","journal-title":"J. Immunol."},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4049\/jimmunol.137.1.245","article-title":"Induction by IL-1 and interferon-\u03b3: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1)","volume":"137","author":"Dustin M. L.","year":"1986","unstructured":"Dustin M. L. Rothlein R. Bhan A. K. Dinarello C. A. Springer T. A. Induction by IL-1 and interferon-\u03b3: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1).J. Immunol.1371986245254","journal-title":"J. Immunol."},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.7.3571-3579.1999"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/1074-7613(95)90001-2"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.23.13806"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.4049\/jimmunol.163.7.3883","article-title":"TNF receptor p55 is required for elimination of inflammatory cells following control of intracellular pathogens","volume":"163","author":"Kanaly S. T.","year":"1999","unstructured":"Kanaly S. T. Nashleanas M. Hondowicz B. Scott P. TNF receptor p55 is required for elimination of inflammatory cells following control of intracellular pathogens.J. Immunol.163199938833889","journal-title":"J. Immunol."},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1080\/00034983.1995.11813016"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.4049\/jimmunol.145.12.4306","article-title":"Tumor necrosis factor-\u03b1 synergizes with IFN-\u03b3 in mediating killing of Leishmania major through the induction of nitric oxide","volume":"145","author":"Liew F. Y.","year":"1990","unstructured":"Liew F. Y. Li Y. Millott S. Tumor necrosis factor-\u03b1 synergizes with IFN-\u03b3 in mediating killing of Leishmania major through the induction of nitric oxide.J. Immunol.145199043064310","journal-title":"J. Immunol."},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.15.8093"},{"key":"e_1_3_2_14_2","unstructured":"Murray H. W. Granulomatous inflammation: host antimicrobial defense in the tissues in visceral leishmaniasis Inflammation: basic principles and clinical correlates 3rd ed. Gallin J. I. Snyderman R. Fearon D. T. Haynes B. F. Nathan C. F. 1999 977 993 Lippincott-Raven Philadelphia Pa"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1086\/516482"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1086\/315268"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.1.288-293.2000"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.7.1504"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/173.4.1041"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.189.4.741"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114009"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"5506","DOI":"10.4049\/jimmunol.160.11.5506","article-title":"Control of Leishmania major infection in mice lacking TNF receptors","volume":"160","author":"Nashleanas M.","year":"1998","unstructured":"Nashleanas M. Kanaly S. Scott P. Control of Leishmania major infection in mice lacking TNF receptors.J. Immunol.160199855065513","journal-title":"J. Immunol."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.3.1428-1434.2000"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1086\/315061"},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1172\/JCI114654","article-title":"Modification of in vitro monocyte cytokine responses to Leishmania donovani: interferon-\u03b3 prevents parasite-induced inhibition of interleukin-1 production and primes monocytes to respond to Leishmania by producing both tumor necrosis factor-\u03b1 and interleukin-1","volume":"85","author":"Reiner N. E.","year":"1990","unstructured":"Reiner N. E. Ng W. Wilson C. B. McMaster W. B. Burchett S. K. Modification of in vitro monocyte cytokine responses to Leishmania donovani: interferon-\u03b3 prevents parasite-induced inhibition of interleukin-1 production and primes monocytes to respond to Leishmania by producing both tumor necrosis factor-\u03b1 and interleukin-1.J. Clin. Investig.85199019141924","journal-title":"J. Clin. Investig."},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.59.11.3935-3944.1991"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/364798a0"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.180.6.2125"},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1002\/eji.1830210713","article-title":"Cytokine interactions in experimental cutaneous leishmaniasis. II. Endogenous tumor necrosis factor-\u03b1 production by macrophages is induced by synergistic action of interferon (IFN)-\u03b3 and interleukin (IL) 4 and accounts for the antiparasitic effect mediated by IFN-\u03b3 and IL 4","volume":"21","author":"Stenger S.","year":"1991","unstructured":"Stenger S. Solbach W. Rollinghoff M. Bogdan C. Cytokine interactions in experimental cutaneous leishmaniasis. II. Endogenous tumor necrosis factor-\u03b1 production by macrophages is induced by synergistic action of interferon (IFN)-\u03b3 and interleukin (IL) 4 and accounts for the antiparasitic effect mediated by IFN-\u03b3 and IL 4.Eur. J. Immunol.21199116691675","journal-title":"Eur. J. Immunol."},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)04367-0"},{"key":"e_1_3_2_31_2","first-page":"2563","article-title":"Immunomodulatory and immunotherapeutic properties of recombinant interferon-\u03b3 and recombinant tumor necrosis factor in mice","volume":"47","author":"Talmadge J. E.","year":"1987","unstructured":"Talmadge J. E. Tribble H. R. Pennington R. W. Phillips H. Wiltrout R. H. Immunomodulatory and immunotherapeutic properties of recombinant interferon-\u03b3 and recombinant tumor necrosis factor in mice.Cancer Res.47198725632570","journal-title":"Cancer Res."},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.185.7.1231"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.10.2228"},{"key":"e_1_3_2_34_2","doi-asserted-by":"crossref","first-page":"768","DOI":"10.4049\/jimmunol.153.2.768","article-title":"Role and effect of TNF-\u03b1 in experimental visceral leishmaniasis","volume":"153","author":"Tumang M. C. T.","year":"1994","unstructured":"Tumang M. C. T. Keogh C. Moldawer L. L. Helfgott D. C. Teitlbaum R. Hariprashad J. Murray H. W. Role and effect of TNF-\u03b1 in experimental visceral leishmaniasis.J. Immunol.1531994768775","journal-title":"J. Immunol."},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.10.040192.002211"},{"key":"e_1_3_2_36_2","doi-asserted-by":"crossref","first-page":"827","DOI":"10.4049\/jimmunol.157.2.827","article-title":"Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication","volume":"157","author":"Vieira L. Q","year":"1996","unstructured":"Vieira L. Q Goldschmidt M. Nashleanas M. Pfeffer K. Mak T. Scott P. Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication.J. Immunol.1571996827835","journal-title":"J. Immunol."},{"key":"e_1_3_2_37_2","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.4049\/jimmunol.160.3.1340","article-title":"Decreased resistance of TNF receptor p55- and p75-deficient mice to chronic toxoplasmosis despite normal activation of inducible nitric oxide synthase in vivo","volume":"160","author":"Yap G. S.","year":"1998","unstructured":"Yap G. S. Scharton-Kersten T. Charest H. Sher A. Decreased resistance of TNF receptor p55- and p75-deficient mice to chronic toxoplasmosis despite normal activation of inducible nitric oxide synthase in vivo.J. Immunol.160199813401345","journal-title":"J. Immunol."},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01202215"}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.68.11.6289-6293.2000","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.68.11.6289-6293.2000","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T15:31:57Z","timestamp":1682263917000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.68.11.6289-6293.2000"}},"subtitle":[],"editor":[{"given":"J. M.","family":"Mansfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2000,11]]},"references-count":37,"aliases":["10.1128\/.68.11.6289-6293.2000"],"journal-issue":{"issue":"11","published-print":{"date-parts":[[2000,11]]}},"alternative-id":["10.1128\/IAI.68.11.6289-6293.2000"],"URL":"https:\/\/doi.org\/10.1128\/iai.68.11.6289-6293.2000","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,11]]},"assertion":[{"value":"2000-04-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2000-08-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2000-11-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}